Learn more about what’s possible when innovation, collaboration, and clinical excellence come together.

GLP-1 medications drive unprecedented growth in traditional drug spending, surpassing specialty drug trends for the first time.

The landscape of liver disease treatment is evolving rapidly. With new diagnostic tools and promising therapies in development, the future of MASH care is brighter than ever.

Equip your clients with proven tools and strategies to boost online registration—helping members unlock the full value of their pharmacy benefit.


Help your clients optimize their GLP-1 prescription spend with the latest EncircleRx enhancement—delivering lower net costs per prescription and offering flexible options to adjust patient cost share for Zepbound® and Wegovy®.